Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (141-150 of 391) with videos related to

Pageof 40
Sort By:
Nature Reviews. Neurology|September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatmentsEric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
Annals of Neurology|April 11, 2009
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous systemRandall J Bateman, Eric R Siemers, Kwasi G Mawuenyega, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|May 13, 2015
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)Nigel J Cairns, Richard J Perrin, Erin E Franklin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2024
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathologyDaniel J Figdore, Heather J Wiste, Joshua A Bornhorst, et al.
Nature Medicine|April 1, 2025
Harnessing artificial intelligence to transform Alzheimer's disease researchSandrine Andrieu, Randall J Bateman, Erika Bereczki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosisVitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research|February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subsetPratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLon S S Schneider, Jorge J Llibre-Guerra, David B Clifford, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
JAMA Neurology|February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer DiseaseSylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Pageof 40

Showing results (141-150 of 391) with videos related to

Sort By:
Pageof 40
Nature Reviews. Neurology|September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatmentsEric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
Annals of Neurology|April 11, 2009
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous systemRandall J Bateman, Eric R Siemers, Kwasi G Mawuenyega, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|May 13, 2015
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)Nigel J Cairns, Richard J Perrin, Erin E Franklin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 2, 2024
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathologyDaniel J Figdore, Heather J Wiste, Joshua A Bornhorst, et al.
Nature Medicine|April 1, 2025
Harnessing artificial intelligence to transform Alzheimer's disease researchSandrine Andrieu, Randall J Bateman, Erika Bereczki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 24, 2017
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosisVitaliy Ovod, Kara N Ramsey, Kwasi G Mawuenyega, et al.
Current Alzheimer Research|February 6, 2015
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subsetPratishtha Chatterjee, Veer B Gupta, Anne M Fagan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentLon S S Schneider, Jorge J Llibre-Guerra, David B Clifford, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
JAMA Neurology|February 27, 2018
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer DiseaseSylvia Villeneuve, Jacob W Vogel, Julie Gonneaud, et al.
Pageof 40